S&P/ASX All Ordinaries Index (ASX: XAO) shares are down 0.26% to 8,857.9 points on Thursday.
Among the 11 market sectors, financials are in the lead today, up 0.4%, as Commonwealth Bank of Australia (ASX: CBA) shares recover modestly from yesterday's mammoth 10.3% drop.
The consumer staples sector is the laggard today, down 2.5%, after an explosive Federal Court judgement against Coles Group Ltd (ASX: COL).
ASX All Ords shares have slipped into the red for 2026, and are currently down 2% in the year to date (YTD).
But the experts say some stocks are on a vastly different path.
Here are four ASX All Ords shares with 12-month share price targets from the experts that suggest significant growth ahead.
Image source: Getty Images
Life360 Inc (ASX: 360)
The Life360 share price is $18.49, down 1.5% today.
Over the past six months, this ASX All Ords tech share has lost 50% of its market valuation.
The substantial decline came amid a broader tech sector rout that ran from late August to 30 March this year.
Since the turnaround began on 31 March, Life360 shares have risen 1.9%.
Life360 shares are vastly underperforming the S&P/ASX 200 Info Tech Index (ASX: XIJ), which is 12.5% higher since 31 March.
Bell Potter is optimistic on Life360 shares and gives the stock a buy rating.
The broker's 12-month price target is $32.50, suggesting 76% upside from here.
Helloworld Travel Ltd (ASX: HLO)
Helloworld Travel shares are down 1.4% to $1.43 apiece, and down 25% YTD.
Shaw and Partners has a buy rating on this ASX All Ords travel share with a 12-month target of $2.80.
This implies 95% capital growth ahead.
Neuren Pharmaceuticals Ltd (ASX: NEU)
The Neuren Pharmaceuticals share price is $12.74, up 0.2% on Thursday.
This ASX All Ords healthcare share has fallen 33% in 2026 so far amid a broader sector downfall.
The S&P/ASX 200 Health Care Index (ASX: XHJ) is also down 33% YTD as the industry battles many headwinds.
However, Bell Potter is confident that Neuren Pharmaceuticals shares will come back.
The broker has renewed its buy rating with a price target of $22.
This implies 73% capital growth over the next 12 months.
Light & Wonder Inc (ASX: LNW)
The Light & Wonder share price is $113.86, down 1.6% today and down 27% YTD.
Bell Potter recently reiterated its buy rating on Light & Wonder shares but lowered its price target from $220 to $190.
This still implies impressive potential growth of 67% ahead for the ASX All Ords gaming share.
